These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2185403)

  • 1. [Inhibition of platelet aggregation by endothelium-derived relaxing factor-like agents].
    Gerzer R; Karrenbrock B; Drummer C; Heim JM
    Med Klin (Munich); 1990 Feb; 85 Suppl 1():18-22. PubMed ID: 2185403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
    Gerzer R; Drummer C; Karrenbrock B; Heim JM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
    Gerzer R; Karrenbrock B; Siess W; Heim JM
    Thromb Res; 1988 Oct; 52(1):11-21. PubMed ID: 2904706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet aggregation with SIN 1: comparison with isosorbide-5-mononitrate and acetylsalicylic acid].
    Gerzer R; Karrenbrock B; Niederreiter B; Heim JM; Drummer C
    Z Kardiol; 1991; 80 Suppl 5():9-11. PubMed ID: 1776339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B; Grewe R; Loeschke K; Gerzer R
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nitrates in cardiology practice].
    Skvaril J
    Cas Lek Cesk; 2000 Jun; 139(11):343-9. PubMed ID: 10953414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molsidomine.
    Reden J
    Blood Vessels; 1990; 27(2-5):282-94. PubMed ID: 2242448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances].
    Bassenge E
    Z Kardiol; 1991; 80 Suppl 5():17-21. PubMed ID: 1776330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of molsidomine on ex vivo platelet aggregation and plasma guanosine 3':5'-cyclic monophosphate levels in healthy volunteers.
    Karrenbrock B; Heim JM; Gerzer R
    Klin Wochenschr; 1990 Feb; 68(4):213-7. PubMed ID: 2156106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct inhibition of platelet function by organic nitrates via nitric oxide formation.
    Weber AA; Strobach H; Schrör K
    Eur J Pharmacol; 1993 Sep; 247(1):29-37. PubMed ID: 8258358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
    Bult H; Fret HR; Herman AG
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endothelial factors and thrombocyte function].
    Schrör K
    Z Kardiol; 1991; 80 Suppl 5():3-6. PubMed ID: 1776333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the influence of nitrates, molsidomine and SIN-1, a molsidomine metabolite in acute coronary insufficiency.
    Degré S; Sobolski J; Berkenboom G; Abramowicz M; Vandermoten P; Stoupel E
    Bibl Cardiol; 1985; (39):129-34. PubMed ID: 3842256
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of the vasodilating effect and blood platelet- antiaggregating activity of molsidomine and SIN-1].
    Kukovetz WR; Holzmann S
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):260-5. PubMed ID: 3031569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man.
    Wolfram G; Meyer U; Scheske U; Horn M; Drummer C; Spannagl M; Gerzer R
    Eur J Med Res; 1996 Mar; 1(6):291-8. PubMed ID: 9367942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
    Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
    Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo.
    Spiecker M; Darius H; Meyer J
    Thromb Res; 1993 Jun; 70(5):405-15. PubMed ID: 7690993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D; Currie MG; Mollace V
    J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molsidomine: importance in treatment of circulation disorders].
    Kmieć M; Ochmański W
    Przegl Lek; 1998; 55(10):532-6. PubMed ID: 10224868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.